Literature DB >> 29527656

Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.

Deepika S Darbari1,2,3,4, Jaquette Liljencrantz4,5, Austin Ikechi6, Staci Martin4,7, Marie Claire Roderick4,7, Courtney D Fitzhugh3,4, John F Tisdale4,8, Swee Lay Thein3,4, Matthew Hsieh4,8.   

Abstract

Entities:  

Keywords:  haematopoietic stem cell transplant; opioids; pain; sickle cell disease

Mesh：

Substances：

Year:  2018        PMID： 29527656      PMCID： PMC6541482          DOI： 10.1111/bjh.15169

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain.

Authors:  Carlton Dampier; Tonya M Palermo; Deepika S Darbari; Kathryn Hassell; Wally Smith; William Zempsky
Journal:  J Pain       Date:  2017-01-05       Impact factor: 5.820

2.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

3.  An Evaluation of Central Sensitization in Patients With Sickle Cell Disease.

Authors:  Claudia M Campbell; Gyasi Moscou-Jackson; C Patrick Carroll; Kasey Kiley; Carlton Haywood; Sophie Lanzkron; Matthew Hand; Robert R Edwards; Jennifer A Haythornthwaite
Journal:  J Pain       Date:  2016-02-16       Impact factor: 5.820

4.  Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; R Patrick Weitzel; Mary E Link; Wynona A Coles; Xiongce Zhao; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

5.  Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  Eliane Gluckman; Barbara Cappelli; Francoise Bernaudin; Myriam Labopin; Fernanda Volt; Jeanette Carreras; Belinda Pinto Simões; Alina Ferster; Sophie Dupont; Josu de la Fuente; Jean-Hugues Dalle; Marco Zecca; Mark C Walters; Lakshmanan Krishnamurti; Monica Bhatia; Kathryn Leung; Gregory Yanik; Joanne Kurtzberg; Nathalie Dhedin; Mathieu Kuentz; Gerard Michel; Jane Apperley; Patrick Lutz; Bénédicte Neven; Yves Bertrand; Jean Pierre Vannier; Mouhab Ayas; Marina Cavazzana; Susanne Matthes-Martin; Vanderson Rocha; Hanadi Elayoubi; Chantal Kenzey; Peter Bader; Franco Locatelli; Annalisa Ruggeri; Mary Eapen
Journal:  Blood       Date:  2016-12-13       Impact factor: 22.113

Review 6.  Thinking beyond sickling to better understand pain in sickle cell disease.

Authors:  Deepika S Darbari; Samir K Ballas; Daniel J Clauw
Journal:  Eur J Haematol       Date:  2014-05-16       Impact factor: 2.997

7.  The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.

Authors:  David Cella; Susan Yount; Nan Rothrock; Richard Gershon; Karon Cook; Bryce Reeve; Deborah Ader; James F Fries; Bonnie Bruce; Mattias Rose
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

8.  Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease.

Authors:  Lauren M Beverung; James W Varni; Julie A Panepinto
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

Review 9.  Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

Authors:  Mark C Walters; Laura M De Castro; Keith M Sullivan; Lakshmanan Krishnamurti; Naynesh Kamani; Christopher Bredeson; Donna Neuberg; Kathryn L Hassell; Stephanie Farnia; Andrew Campbell; Effie Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-21       Impact factor: 5.742

10.  Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.

Authors:  San Keller; Manshu Yang; Marsha J Treadwell; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2017-06-02       Impact factor: 3.186
  10 in total
  9 in total

Review 1.  Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Authors:  Gregory M T Guilcher; Tony H Truong; Santosh L Saraf; Jacinth J Joseph; Damiano Rondelli; Matthew M Hsieh
Journal:  Semin Hematol       Date:  2018-04-25       Impact factor: 3.851

Review 2.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

3.  Red blood cell transfusion therapy for sickle cell patients with frequent painful events.

Authors:  Lee M Hilliard; Varsha Kulkarni; Bisakha Sen; Cathy Caldwell; Christina Bemrich-Stolz; Thomas H Howard; Amanda Brandow; Emily Waite; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-27       Impact factor: 3.167

4.  Optimal disease management and health monitoring in adults with sickle cell disease.

Authors:  Jo Howard; Swee Lay Thein
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Hematopoietic cell transplantation for sickle cell disease: updates and future directions.

Authors:  Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 6.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

7.  American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.

Authors:  Julie Kanter; Robert I Liem; Françoise Bernaudin; Javier Bolaños-Meade; Courtney D Fitzhugh; Jane S Hankins; M Hassan Murad; Julie A Panepinto; Damiano Rondelli; Shalini Shenoy; John Wagner; Mark C Walters; Teonna Woolford; Joerg J Meerpohl; John Tisdale
Journal:  Blood Adv       Date:  2021-09-28

Review 8.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

Review 9.  Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease.

Authors:  Santosh L Saraf; Damiano Rondelli
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.